Metacavir (6-O-methyl-2′, 3′-dideoxyguanosine) is a reverse transcriptase inhibitor with potent activity against hepatitis B virus (HBV): it is a prodrug that is activated in vivo by demethylation and conversion to 2′, 3′-dideoxyguanosine.
Metacavir (6-O-methyl-2′, 3′-dideoxyguanosine) is a reverse transcriptase inhibitor with potent activity against hepatitis B virus (HBV): it is a prodrug that is activated in vivo by demethylation and conversion to 2′, 3′-dideoxyguanosine.